a nurse is caring for a client who has a new prescription for somatropin to stimulate growth the nurse should instruct the client to monitor for which

ATI RN

ATI Pharmacology Test Bank

1. A client has a new prescription for Somatropin to stimulate growth. The client should monitor for which of the following adverse effects?

A. Hyperglycemia.
B. Bradycardia.
C. Urinary frequency.
D. Edema.

Correct answer: A

Rationale: Somatropin is known to cause hyperglycemia as a common adverse effect. Therefore, the client should be instructed to monitor for elevated blood glucose levels closely while taking this medication to ensure early detection and management of hyperglycemia.

2. A client has a new prescription for Alendronate. Which of the following instructions should be included in the discharge teaching?

A. Take this medication at bedtime.
B. Remain upright for 30 minutes after taking the medication.
C. Take this medication with food.
D. Increase your intake of calcium-rich foods.

Correct answer: B

Rationale: The correct answer is to instruct the client to remain upright for 30 minutes after taking Alendronate. This medication can cause esophageal irritation, and maintaining an upright position for at least 30 minutes helps prevent complications such as esophagitis or esophageal ulcers. Choice A is incorrect because Alendronate should be taken in the morning on an empty stomach. Choice C is incorrect because Alendronate should be taken on an empty stomach, preferably 30 minutes before the first food, beverage, or medication of the day. Choice D is incorrect because while calcium intake is important, it is not a specific instruction related to taking Alendronate.

3. Which drug undergoes extensive first-pass hepatic metabolism?

A. Heparin
B. Insulin
C. Propranolol
D. Nitroglycerin

Correct answer: C

Rationale: Propranolol undergoes extensive first-pass hepatic metabolism in the liver. When administered orally, propranolol is extensively metabolized by the liver before reaching systemic circulation, leading to reduced bioavailability. This process is known as first-pass hepatic metabolism, which significantly affects the drug's effectiveness and necessitates higher oral doses compared to other routes of administration. Heparin (Choice A) is not metabolized by the liver but excreted unchanged by the kidneys. Insulin (Choice B) is a peptide hormone that is not subject to significant first-pass metabolism. Nitroglycerin (Choice D) is primarily metabolized in the blood and tissues, bypassing significant first-pass metabolism in the liver.

4. Which of the following is not a side effect of the cholinoreceptor blocker (Atropine)?

A. Increased pulse
B. Diarrhea
C. Constipation
D. Mydriasis

Correct answer: B

Rationale: Atropine, an anticholinergic drug, commonly causes side effects like increased pulse, mydriasis (dilated pupils), and constipation due to its inhibitory effect on the parasympathetic nervous system. Diarrhea is not typically a side effect of Atropine, making it the correct answer.

5. Which of the following conditions is not treated with Lansoprazole?

A. Zollinger-Ellison syndrome
B. Gastritis
C. Hypertension
D. Reflux

Correct answer: C

Rationale: Lansoprazole is a proton pump inhibitor used to treat conditions related to excessive stomach acid production, such as Zollinger-Ellison syndrome, gastritis, and reflux. However, it is not indicated for the treatment of hypertension, which is managed using antihypertensive medications. Therefore, the correct answer is C: Hypertension.